Concepedia

Christopher Becker

CB

Statistics

Publications

12

Citations

470

H-Index

11

Active since

2007

Affiliations

AstraZeneca (United States)(Current)

University of Michigan

University of Cincinnati Medical Center

University of Pittsburgh

University of Pennsylvania

Christopher Becker is an author at AstraZeneca (United States) specializing in pharmacology, drug discovery, and pharmacy.

ORCID

Publications per year

2007–2024

12

Publications

12

Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy

Hooman Kamel, W. T. Longstreth, David Tirschwell et al. · JAMA · 2024 · 181 citations · Full text

, , +17

Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors

Peng Cui, Jose L. Tomsig, William McCalmont et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 66 citations · Full text

, , +11

Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors

Jesús R. Medina, Christopher Becker, Charles W. Blackledge et al. · Journal of Medicinal Chemistry · 2011 · 54 citations · Full text

, , +13

Potent Nonimmunosuppressive Cyclophilin Inhibitors With Improved Pharmaceutical Properties and Decreased Transporter Inhibition

Jiping Fu, Meiliana Tjandra, Christopher Becker et al. · Journal of Medicinal Chemistry · 2014 · 31 citations · Full text

, , +17

Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1

Todd A. Brugel, Reed W. Smith, Michael Balestra et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 26 citations · Full text

, , +14

1–5 of 12